Last reviewed · How we verify
NCT03525158
A Brief Cognitive Intervention After Intrusive Memories of Trauma With Young Refugees
NA trial testing Brief cognitive intervention in Intrusive Memories of Trauma, Symptom of Post Traumatic Stress Disorder (Criterion B1) in 4 participants. Completed in 26 February 2018.
26 February 2018
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 4 |
| Start date | 20 June 2017 |
| Primary completion | 26 February 2018 |
| Estimated completion | 26 February 2018 |
| Sites | 2 locations across Sweden |
Drugs / interventions tested
- Brief cognitive intervention
Conditions studied
- Intrusive Memories of Trauma, Symptom of Post Traumatic Stress Disorder (Criterion B1) — all drugs for Intrusive Memories of Trauma, Symptom of Post Traumatic Stress Disorder (Criterion B1) →
Sponsor
Karolinska Institutet
Who can join
Adults 16 to 25, any sex, with Intrusive Memories of Trauma, Symptom of Post Traumatic Stress Disorder (Criterion B1). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study is designed to investigate the use of a simple cognitive task (a memory cue and 10 minute time gap, followed by playing the computer game "Tetris") for decreasing the number of intrusive memories of trauma among young refugees and asylum seekers. The design is a single case experimental AB design with or without optional replication (ABAB). Participants will aim to complete a no-intervention phase ('A': baseline phase) of one week followed by a one-week intervention phase ('B'), including a one-session intervention with a researcher comprising the simple cognitive task, followed by instructions to continue to use the technique self-guided in the subsequent week. Follow ups are conducted after each week to monitor the occurrence of intrusive memories of trauma in a pen-and-paper diary. It is predicted that participants will report fewer intrusive memories during the intervention phase than during the preceding baseline phase.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03525158
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Brief cognitive intervention
Trials testing the same drug.
- NCT04394156 — Reducing Intrusive Memories in Refugees and Asylum Seekers With PTSD · NA · terminated
- NCT04394832 — Reducing Intrusive Memories in Refugees and Asylum Seekers With PTSD: A Pilot Study · NA · terminated
- NCT03760601 — A Brief Cognitive Intervention After Intrusive Memories of Trauma With Young Refugees: An Extension · NA · completed
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03525158 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 18 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525158.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing